AlphaYouHB
Insider selling
Harold Bernstein sold $393K of Maze Therapeutics, Inc. (MAZE) stock
Harold Bernstein, President, R&D & CMO of Maze Therapeutics, Inc. (MAZE), sold 15,000 shares of MAZE stock worth $393K, per an SEC Form 4 filed May 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 14, 2026, 4 days before it was made public.
MAZE has moved -15.3% since the trade date, from $26.43 to $22.39 (Sep 21, 2026 close).
- Traded
- May 14, 2026
- Disclosed
- May 18, 2026
- Filing delay
- 4 days
- Price since
- -15.3%
- Role
- President, R&D & CMO
- Source
- SEC Form 4
More MAZE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.